InGeneron Publishes Significant Support for the Existence of Naturally Pluripotent Stem Cells in All Organs in the Adult Body
InGeneron Extends Series D Financing to $43 Million to Bring Regenerative Cell Therapy into the Clinic
InGeneron Expands Development Pipeline with Two Osteoarthritis Programs
InGeneron Reports Positive Top-Line Data From its Clinical Lead Program in Rotator Cuff Tendinopathy
InGeneron Announces Publication of Positive Results from Investigator-Initiated Wound Healing Case Series Using Company’s Regenerative Cell Technology
InGeneron Completes Strategic Financing from Sanford Health to Advance Regenerative Cell Therapies
InGeneron Establishes Presence in Cambridge, MA and Initiates Collaboration with German Accelerator Life Sciences
InGeneron Announces Presentation of Results from Investigator Initiated Case Series of its Regenerative Cell Therapy in Chronic Back Pain at IFATS
In the US InGeneron’s Transpose® RT cell therapy platform is for investigational use only. By Clicking ‘Continue’ I confirm acknowledgment
